Oral CELMoD Mezigdomide May Address Logistical Challenges Linked With R/R Myeloma Management
Paul G. Richardson, MD, shares clinical findings and several case studies showcasing the encouraging activity and safety of mezigdomide in patients with relapsed/refractory multiple myeloma.